Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
197.00
162.00
179.00
140.00
115.00
112.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
197.00
162.00
179.00
140.00
115.00
112.00
Expenditure (Ex Depriciation)
Stock Adjustments
7.00
-6.00
-12.00
-9.00
-3.00
1.00
Raw Materials Consumed
94.00
90.00
104.00
81.00
55.00
68.00
Power & Fuel Cost
7.00
6.00
7.00
5.00
5.00
2.00
Employee Cost
34.00
31.00
30.00
20.00
14.00
9.00
Operating Expenses
11.00
9.00
8.00
7.00
7.00
7.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
10.00
6.00
7.00
3.00
3.00
1.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
1.00
1.00
1.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
177.00
148.00
155.00
116.00
91.00
93.00
Operating Profit (PBDIT) excl Other Income
20.00
14.00
23.00
24.00
24.00
19.00
Other Income
3.00
6.00
2.00
2.00
1.00
0.00
Operating Profit (PBDIT)
23.00
20.00
25.00
26.00
25.00
20.00
Interest
4.00
3.00
5.00
3.00
1.00
1.00
Profit before Depriciation and Tax
19.00
16.00
20.00
23.00
23.00
18.00
Depreciation
7.00
7.00
7.00
6.00
5.00
2.00
Profit Before Taxation & Exceptional Items
11.00
9.00
13.00
17.00
18.00
16.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
11.00
9.00
13.00
17.00
18.00
16.00
Provision for Tax
2.00
3.00
3.00
2.00
3.00
4.00
Profit After Tax
9.00
6.00
9.00
14.00
14.00
12.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
96.00
90.00
82.00
68.00
55.00
43.00
Profit Available for appropriations
105.00
97.00
93.00
83.00
70.00
55.00
Appropriations
105.00
97.00
93.00
83.00
70.00
55.00
Equity Dividend (%)
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
Earnings Per Share
7.22
5.16
7.50
11.64
12.19
9.93
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 21.67% vs -9.35% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 43.79% vs -38.67% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 24.95% vs -34.40% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 49.43% vs -30.95% in Mar 2025
Compare Profit and Loss Results of Medicamen Biotec
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
197.00
0
197.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
197.00
0
197.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
7.00
0
7.00
0%
Raw Materials Consumed
94.00
0
94.00
0%
Power & Fuel Cost
7.00
0
7.00
0%
Employee Cost
34.00
0
34.00
0%
Operating Expenses
11.00
0
11.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
10.00
0
10.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
177.00
0
177.00
0%
Operating Profit (PBDIT) excl Other Income
20.00
0.00
20.00
0%
Other Income
3.00
0
3.00
0%
Operating Profit (PBDIT)
23.00
0
23.00
0%
Interest
4.00
0
4.00
0%
Profit before Depriciation and Tax
19.00
0
19.00
0%
Depreciation
7.00
0
7.00
0%
Profit Before Taxation & Exceptional Items
11.00
0
11.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
11.00
0
11.00
0%
Provision for Tax
2.00
0
2.00
0%
Profit After Tax
9.00
0
9.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
96.00
0
96.00
0%
Profit Available for appropriations
105.00
0
105.00
0%
Appropriations
105.00
0
105.00
0%
Equity Dividend (%)
10%
0%
10.00
Earnings Per Share
7.22
0
7.22
0%
Profit And Loss - Net Sales
Net Sales 197.77 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 21.67% vs -9.35% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 43.79% vs -38.67% in Mar 2025
Profit And Loss - Interest
Interest 4.65 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 24.95% vs -34.40% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 9.80 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 49.43% vs -30.95% in Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
